Bayer

  • Mirena 2015 report

    Mirena 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 20 Pages The 5 Key Questions Addressed by this...

  • Nexavar 2015 report

    Nexavar 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 31 Pages The 5 Key Questions Addressed by this...

  • Skyla 2015 report

    Skyla 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 20 Pages The 5 Key Questions Addressed by this...

  • Stivarga 2015 report

    Stivarga 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 27 Pages The 5 Key Questions Addressed by this...

  • Xofigo 2015 report

    Xofigo 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 29 Pages The 5 Key Questions Addressed by this...

  • Adempas 2014 report

    Adempas 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 28 Pages The 5 Key Questions Addressed by this...

  • Betaseron 2014 report

    Betaseron 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 18 Pages The 5 Key Questions Addressed by this...

  • Desonate 2014 report

    Desonate 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 20 Pages The 5 Key Questions Addressed by this...

  • Finacea 2014 report

    Finacea 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 18 Pages The 5 Key Questions Addressed by this...

  • Gadavist 2014 report

    Gadavist 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Kogenate 2014 report

    Kogenate 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Mirena 2014 report

    Mirena 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 20 Pages The 5 Key Questions Addressed by this...